| Financial Year |
March 31 2022 |
| Monetary Funds |
647,816,736.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
40,689,245.39 |
| Accounts Receivable |
1,269,774,167.14 |
| Advances to Suppliers |
11,460,226.62 |
| Other Receivables |
22,213,905.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,006,758,204.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,452,011.88 |
| Total Current Assets |
3,120,506,373.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,441,036.22 |
| Investment Properties |
23,091,305.53 |
| Fixed Assetes |
473,142,832.06 |
| Under-construction Projects |
121,781,603.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
237,824,272.45 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
54,955,736.04 |
| Other Non-Current Assets |
26,848,612.07 |
| Sub-Total of Non-Current Assets |
961,850,495.06 |
| Total Assets |
4,082,356,868.52 |
| Short-Term Loans |
150,123,611.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
201,226,000.00 |
| Accounts Payable |
1,274,546,293.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,704,588.05 |
| Taxes Payable |
17,990,884.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
93,920,187.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,501,279.27 |
| Other Current Liabilities |
19,994,180.17 |
| Sub-Total of Current Liabilities |
1,846,639,435.51 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
34,485,616.81 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
193,283,947.07 |
| Total Liabilities |
2,039,923,382.58 |
| Paid-In Capital(Or Share Stock) |
533,333,400.00 |
| Capital Surplus |
998,447,860.56 |
| Surplus Reserve |
42,693,795.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
467,958,429.91 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,042,433,485.94 |
| Owner's Equity（Stockholder's Equity） |
2,042,433,485.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,082,356,868.52 |
